Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Proceeds from Sale of Productive Assets

2.0 / 5 stars · 33/81 Roast Me

CAPRICOR THERAPEUTICS, INC. Proceeds from Sale of Productive Assets

CAPRICOR THERAPEUTICS, INC. (CAPR) reported Proceeds from Sale of Productive Assets of $2.50 thousand for the 98-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.

Discontinued › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2013-11-14

  • CAPRICOR THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2013-09-30 was $0.00.
  • CAPRICOR THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2013-06-30 was $0.00.
  • CAPRICOR THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2013-03-31 was $0.00.
  • CAPRICOR THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2012-12-31 was $0.00.
  • CAPRICOR THERAPEUTICS, INC. proceeds from sale of productive assets for fiscal 2012 was $0.00.
  • CAPRICOR THERAPEUTICS, INC. proceeds from sale of productive assets for fiscal 2011 was $0.00.
Period endProceeds from Sale of Productive Assets 3 monthProceeds from Sale of Productive Assets 6 monthProceeds from Sale of Productive Assets 9 monthProceeds from Sale of Productive Assets 12 monthProceeds from Sale of Productive Assets 83 monthProceeds from Sale of Productive Assets 86 monthProceeds from Sale of Productive Assets 89 monthProceeds from Sale of Productive Assets 92 monthProceeds from Sale of Productive Assets 95 monthProceeds from Sale of Productive Assets 98 month
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
10-Q · filed 2013-11-14
$0.00
derived: sum of 4 quarters · filed 2013-11-14
$2.50K
10-Q · filed 2013-11-14
2013-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$0.00
10-Q · filed 2013-08-14
$0.00
derived: sum of 3 quarters · filed 2013-08-14
$0.00
derived: sum of 4 quarters · filed 2013-11-14
$2.50K
10-Q · filed 2013-08-14
2013-03-31$0.00
10-Q · filed 2013-06-21
$0.00
derived: sum of 2 quarters · filed 2013-06-21
$0.00
derived: sum of 3 quarters · filed 2013-11-14
$0.00
derived: sum of 4 quarters · filed 2013-11-14
$2.50K
10-Q · filed 2013-06-21
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
derived: sum of 3 quarters · filed 2013-11-14
$0.00
10-K · filed 2013-06-21
$2.50K
10-K · filed 2013-06-21
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
10-Q · filed 2013-11-14
$0.00
derived: sum of 4 quarters · filed 2013-11-14
$2.50K
10-Q · filed 2013-06-21
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$0.00
10-Q · filed 2013-08-14
$0.00
derived: sum of 3 quarters · filed 2013-08-14
$2.50K
10-Q/A · filed 2012-09-10
2012-03-31$0.00
10-Q · filed 2013-06-21
$0.00
derived: sum of 2 quarters · filed 2013-06-21
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21
$0.00
10-K · filed 2013-06-21
2011-09-30$0.00
10-Q · filed 2013-06-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63